BPB
Badgley, Phelps & Bell Portfolio holdings
AUM
$2.69B
1-Year Return
41.96%
This Quarter Return
+1.61%
1 Year Return
+41.96%
3 Year Return
+78.29%
5 Year Return
+148.08%
10 Year Return
–
AUM
$1.5B
AUM Growth
+$45.9M
(+3.2%)
Cap. Flow
+$38.4M
Cap. Flow
% of AUM
2.56%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
202
New
8
Increased
94
Reduced
61
Closed
15
Top Buys
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$14.7M |
| 2 |
NVIDIA
NVDA
|
+$9.97M |
| 3 |
FRC
First Republic Bank
FRC
|
+$8.34M |
| 4 |
Estee Lauder
EL
|
+$7.94M |
| 5 |
RTN
Raytheon Company
RTN
|
+$7.82M |
Top Sells
| 1 |
MetLife
MET
|
+$8.6M |
| 2 |
Wells Fargo
WFC
|
+$8.19M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$7.44M |
| 4 |
Qualcomm
QCOM
|
+$7.11M |
| 5 |
CELG
Celgene Corp
CELG
|
+$7.02M |
Sector Composition
| 1 | Technology | 12.29% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 8.72% |
| 4 | Consumer Discretionary | 7.34% |
| 5 | Industrials | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Avanos Medical
AVNS
$571M
| $691K | 0.05% |
15,000
| – | – |
|
127
AT&T
T
$209B
| $636K | 0.04% |
23,649
-5,304
| -18% | -$143K |
|
128
Novo Nordisk
NVO
$241B
| $623K | 0.04% |
25,280
+800
| +3% | +$19.7K |
|
129
EPAM Systems
EPAM
$9.07B
| $607K | 0.04% |
5,300
| – | – |
|
|
NBL
130
DELISTED
Noble Energy, Inc.
NBL
| $596K | 0.04% |
19,670
| – | – |
|
131
Accenture
ACN
$155B
| $587K | 0.04% |
3,827
| – | – |
|
|
ARRY
132
DELISTED
Array Biopharma Inc
ARRY
| $563K | 0.04% |
34,500
-3,000
| -8% | -$49K |
|
133
Neogen
NEOG
$1.23B
| $536K | 0.04% |
16,000
| – | – |
|
|
BAY
134
DELISTED
BAYER AG SPONS ADR
BAY
| $519K | 0.03% |
18,370
| – | – |
|
135
Blackrock
BLK
$171B
| $513K | 0.03% |
947
-179
| -16% | -$97K |
|
136
Vertex Pharmaceuticals
VRTX
$102B
| $512K | 0.03% |
3,144
-400
| -11% | -$65.1K |
|
|
137
Qualcomm
QCOM
$170B
| $501K | 0.03% |
9,037
-128,276
| -93% | -$7.11M |
|
|
AABA
138
DELISTED
Altaba Inc. Common Stock
AABA
| $500K | 0.03% |
6,750
| – | – |
|
139
Roper Technologies
ROP
$55.9B
| $491K | 0.03% |
1,750
-130
| -7% | -$36.5K |
|
140
Philip Morris
PM
$256B
| $470K | 0.03% |
4,732
+486
| +11% | +$48.3K |
|
141
Biogen
BIIB
$20.9B
| $449K | 0.03% |
1,638
+26
| +2% | +$7.13K |
|
142
Merck
MRK
$210B
| $439K | 0.03% |
8,446
-1,280
| -13% | -$66.5K |
|
143
Nike
NKE
$111B
| $439K | 0.03% |
6,610
-1,333
| -17% | -$88.5K |
|
144
SPDR S&P 500 ETF Trust
SPY
$665B
| $437K | 0.03% |
1,659
-289
| -15% | -$76.1K |
|
145
Heritage Financial
HFWA
$845M
| $436K | 0.03% |
14,247
| – | – |
|
146
CVS Health
CVS
$91.8B
| $414K | 0.03% |
6,662
-3,777
| -36% | -$235K |
|
147
General Mills
GIS
$26.7B
| $408K | 0.03% |
9,047
-118
| -1% | -$5.32K |
|
148
Universal Display
OLED
$6.64B
| $404K | 0.03% |
4,000
| – | – |
|
149
Becton Dickinson
BDX
$54.4B
| $390K | 0.03% |
1,844
| – | – |
|
150
Novartis
NVS
$246B
| $390K | 0.03% |
5,389
-202
| -4% | -$14.6K |
|